Mwandishi:
Mhariri:
Imeboershwa:
ULY CLINIC
ULY CLINIC
17 Februari 2026, 14:31:27
Scabies
Scabies is a highly contagious skin infestation caused by the mite Sarcoptes scabiei var. hominis, which burrows into the epidermis to lay eggs.
Transmission occurs primarily via prolonged skin-to-skin contact, and less commonly via contaminated bedding or clothing.
Crowded living conditions, poor hygiene, and close contact (households, dormitories, refugee camps) increase the risk.
The incubation period for a first infestation is usually 2–6 weeks, whereas reinfestation may cause symptoms within 1–4 days due to prior sensitization.
Epidemiology:
Scabies affects all age groups but is most common in children and young adults.
Immunocompromised individuals are at higher risk of developing severe forms, including crusted (Norwegian) scabies.
Signs & Symptoms
Classic Scabies:
Intense pruritus, often worse at night
Papules, vesicles, and nodules, especially in interdigital spaces, wrists, elbows, axillae, waist, genitalia, and buttocks
Burrows: short, elevated, serpiginous tracks in the superficial epidermis
Excoriation and secondary bacterial infections due to scratching
Crusted (Norwegian) Scabies:
Thick, hyperkeratotic crusts resembling psoriasis
Extensive scaling over palms, soles, elbows, knees, and scalp
Often mild pruritus despite heavy infestation
More common in immunocompromised or debilitated patients
Complications:
Secondary bacterial infections (Staphylococcus aureus, Streptococcus pyogenes)
Impetiginization, cellulitis, or post-streptococcal glomerulonephritis
Spread to close contacts if untreated
Diagnostic Criteria
Clinical diagnosis is generally sufficient:
Intense nocturnal itching
Papules, vesicles, nodules in characteristic locations
Burrows (short elevated S-shaped tracks)
Crusted lesions in Norwegian scabies
Household contacts often symptomatic
Laboratory confirmation (rarely needed):
Skin scraping: Mites, eggs, or fecal pellets observed under microscopy
Dermoscopy: Visualize burrows or mites
Ink test: Ink applied to suspected burrow shows linear patterns
Investigation
Microscopic examination of skin scrapings for mites, eggs, or feces
Dermatoscopy to visualize burrows in atypical cases
Assessment of secondary bacterial infection via swab if necessary
Evaluation of household contacts
Treatment
Non-Pharmacological Treatment
Treat all household contacts simultaneously, regardless of symptoms, to prevent reinfestation
Clean environment: Wash clothing, bedding, and towels in hot water and dry thoroughly
Avoid skin-to-skin contact until treatment is completed
Advise short-term isolation in institutional settings during treatment
Pharmacological Treatment
Topical therapy (first-line):
Benzyl Benzoate Emulsion (BBE):
Adults and children >2 years: Apply from neck down, covering all body surfaces and folds; leave for 24 hours, repeat after 3 days
Children 2 months–2 years: Leave emulsion for 6–8 hours, repeat after 3 days
Babies <2 months: Use sulphur ointment 5% daily for 3 days or lindane lotion 1% applied as above
Other topical agents:
Permethrin 5% cream: Apply from neck down, leave for 8–14 hours, repeat in 7 days if needed
Crotamiton 10% cream: Alternative for sensitive patients
Systemic therapy (for crusted or refractory scabies):
Ivermectin 200 µg/kg orally, repeat in 7–14 days
Often combined with topical agents in severe cases
Adjunctive measures:
Antihistamines for symptomatic relief of pruritus
Topical antibiotics for secondary bacterial infections
Special considerations:
Norwegian scabies requires combination therapy: systemic ivermectin + topical permethrin, repeated as necessary
Immunocompromised patients may need prolonged therapy and close follow-up
Prevention
Avoid prolonged skin-to-skin contact with infected individuals
Immediate treatment of affected contacts
Environmental decontamination: Wash bedding and clothing in hot water; dry in sunlight or hot dryer
Education on early recognition and seeking prompt treatment
Regular screening in institutional settings
References
Chosidow O. Clinical practices. Scabies. N Engl J Med. 2006;354:1718–1727.
Strong M, Johnstone P. Interventions for treating scabies. Cochrane Database Syst Rev. 2007;(3):CD000320.
Engelman D, Kiang K, Chosidow O, et al. The 2020 International Alliance for the Control of Scabies (IACS) consensus criteria for the diagnosis of scabies. Br J Dermatol. 2020;183:808–820.
Tanzania Ministry of Health. Standard Treatment Guidelines & National Essential Medicines List (STG/NEMLIT). 7th ed. Dodoma: MoH; 2023.
Imeandikwa;
3 Novemba 2020, 11:23:15
